Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2018-10-05 2018-10-05
Drug Identification Number 02345587 02345587
Brand name APO-RABEPRAZOLE APO-RABEPRAZOLE
Common or Proper name RABEPRAZOLE RABEPRAZOLE
Company Name APOTEX INC APOTEX INC
Ingredients RABEPRAZOLE SODIUM RABEPRAZOLE SODIUM
Strength(s) 20MG 20MG
Dosage form(s) TABLET (ENTERIC-COATED) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-09-30 2018-09-30
Actual discontinuation date 2018-09-28 2018-09-28
Remaining supply date 2018-09-30 2018-09-30
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments